COORDINATION OF E COLI RIBOSOMAL PROTEIN SYNTHESIS
Project Number7R01AI015286-18
Contact PI/Project LeaderLINDAHL, LASSE A
Awardee OrganizationUNIVERSITY OF MARYLAND BALTIMORE
Description
Abstract Text
The synthesis of ribosomes is regulated in response to environment and
development. A well-documented example of this is the growth rate
control of ribosome synthesis in Escherichia coli. The goal of this
project is to unravel the molecular mechanisms underlying this
regulation. The information gained by this study should contribute to
tbe understanding of regulation of cell growth. It will also elucidate
mechanistic aspects of the processes of transcription termination and
translation initiation.
The E. coli ribosomal protein L-4, encoded by the third gene of the
eleven gene S10 operon, is a multifunctional protein which serves as a
ribosomal component and as a regulator of both transcription termination
in the S10 leader and translation of the first gene of the operon. The
purpose of the experiments proposed here is to provide a detailed
molecular model for the two regulatory processes induced by excess L4.
Currently it is known that transcription termination requires L4, NusA
and certain leader sequences, but it is not clear how these components
interact to prompt the RNA polymerase to terminate transcription at a
specific site. Furthermore, it appears likely that additional
component(s) are necessary for completion of the terrmination process.
The mechanism for the translation control has not yet been elucidated.
A proposed role of alternative secondary RNA structures will be tested
and in vitro systems will be established for biochemical analysis of the
translation regulation. Finally, L4 mutants will be analyzed to
identify domains involved in the protein's various functions.
Other experiments will explore new features of the regulation of the S10
operon: (i) possible upstream activating sequences, (ii) possible
involvement of sequences outside of the promoter region in steady state
growth control, and (iii) expression during stationary phase and out
growth.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
188435911
UEI
Z9CRZKD42ZT1
Project Start Date
01-July-1978
Project End Date
31-May-1996
Budget Start Date
01-September-1994
Budget End Date
31-May-1995
Project Funding Information for 1994
Total Funding
$184,204
Direct Costs
$126,750
Indirect Costs
$57,454
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Allergy and Infectious Diseases
$184,204
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01AI015286-18
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01AI015286-18
Patents
No Patents information available for 7R01AI015286-18
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01AI015286-18
Clinical Studies
No Clinical Studies information available for 7R01AI015286-18
News and More
Related News Releases
No news release information available for 7R01AI015286-18
History
No Historical information available for 7R01AI015286-18
Similar Projects
No Similar Projects information available for 7R01AI015286-18